
Cognitive Decline Biomarker, Tirofiban's Impact on Stroke, Peer Reviewers' Use of Artificial Intelligence
16/7/2026
0:00
4:58
In this episode, editor-in-chief Joseph E. Safdieh, MD, FAAN, highlights articles about a blood test that could predict cognitive decline before pathological signs, the use of tirofiban after tenecteplase for stroke, and the role of artificial intelligence in peer review.
Otros episodios de "Neurology Today in 5"



No te pierdas ningún episodio de “Neurology Today in 5”. Síguelo en la aplicación gratuita de GetPodcast.








